8 months ago
IBRX
AnalystsEdward TenthoffEdward Tenthoff's Stock Forecasts
AnalystsEdward Tenthoff
Sectors:
Analyst Ranking
Bottom 3%
#5438 out of 5548 analysts
Average Return
-5.54%
Win Rate
33%70 out of 214
Risk vs Reward
Poor
Good
Edward Tenthoff's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +743.59% | $23.72 | $200.10 | 2025-11-21 - 2026-10-23 | Strong Buy |
Century Therapeutics IncIPSC | +352.73% | $0.55 | $2.49 | 2025-03-20 - 2026-03-19 | Strong Buy |
Moderna IncMRNA | +297.89% | $50.29 | $200.10 | 2026-02-23 - 2026-10-23 | Strong Buy |
Omega Therapeutics IncOMGAQ | +267.18% | $2.62 | $9.62 | 2022-05-23 - 2023-05-22 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +249.48% | $3.84 | $13.42 | 2017-11-27 - 2018-11-27 | Strong Buy |
Edward Tenthoff Analyst Color
Get additional color on Edward Tenthoff's coverage of popular stocks
3 years ago
ARWR
4 years ago
FULC
4 years ago
STRO
4 years ago
MRNA
4 years ago
ALNY
4 years ago
RAPT
4 years ago
ASLN
4 years ago
MCRB
4 years ago
PSTX
4 years ago
CRSP
5 years ago
ALNY
5 years ago
ARGX
5 years ago
MRNA
Edward Tenthoff's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Opko Health IncOPK | 6 | Strong Buy | $4.00 | +145.40% | Reiterates | 8 days ago |
Dyne Therapeutics IncDYN | 6 | Strong Buy | $47.00 | +200.90% | Reiterates | 25 days ago |
Capricor Therapeutics IncCAPR | 5 | Strong Buy | $25.00 | +321.59% | Upgrades | 2 months ago |
Mesoblast LtdMESO | 6 | Strong Buy | $39.00 | +217.59% | Reiterates | 2 months ago |
Fate Therapeutics IncFATE | 6 | Strong Buy | $8.00 | +279.15% | Reiterates | 2 months ago |
Camp4 Therapeutics CorpCAMP | 3 | Strong Buy | $15.00 | +354.55% | Reiterates | 2 months ago |
Inovio Pharmaceuticals IncINO | 3 | Strong Buy | $4.00 | +345.93% | Reiterates | 3 months ago |
Karyopharm Therapeutics IncKPTI | 4 | Strong Buy | $7.00 | +1,253.97% | Maintains | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 12 | Strong Buy | $126.00 | +117.17% | Reiterates | 3 months ago |
Moderna IncMRNA | 14 | Strong Buy | $77.00 | -61.52% | Maintains | 4 months ago |
Fulcrum Therapeutics IncFULC | 7 | Strong Sell | $3.00 | -18.48% | Downgrades | 5 months ago |
Generate Biomedicines IncGENB | 1 | Strong Buy | $24.00 | +93.39% | Initiates Coverage On | 7 months ago |
Crispr Therapeutics AgCRSP | 6 | Strong Buy | $110.00 | +122.72% | Reiterates | 7 months ago |
Immunitybio IncIBRX | 1 | Strong Buy | $12.00 | +45.99% | Reiterates | 8 months ago |
Cardiff Oncology IncCRDF | 1 | Strong Buy | $6.00 | +561.52% | Maintains | 8 months ago |
Arvinas IncARVN | 7 | Strong Buy | $20.00 | +173.97% | Reiterates | 8 months ago |
Century Therapeutics IncIPSC | 9 | Strong Buy | $4.00 | +173.97% | Maintains | 9 months ago |
Monte Rosa Therapeutics IncGLUE | 4 | Strong Buy | $37.00 | +241.33% | Reiterates | 9 months ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $8.00 | +362.43% | Maintains | 9 months ago |
Kymera Therapeutics IncKYMR | 5 | Strong Buy | $125.00 | +12.86% | Reiterates | a year ago |
Alnylam Pharmaceuticals IncALNY | 7 | Strong Buy | $489.00 | +118.27% | Reiterates | a year ago |
Nextcure IncNXTC | 5 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Sutro Biopharma IncSTRO | 7 | Strong Buy | $20.00 | N/A | Upgrades | a year ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $7.00 | N/A | Assumes | a year ago |
Iteos Therapeutics IncITOS | 1 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Legend Biotech CorpLEGN | 4 | Strong Buy | $78.00 | N/A | Reiterates | 2 years ago |
Xencor IncXNCR | 3 | Strong Buy | $30.00 | N/A | Upgrades | 2 years ago |
Omega Therapeutics IncOMGAQ | 5 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Kronos Bio IncKRON | 6 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Tempest Therapeutics IncTPST | 4 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Skye Bioscience IncSKYE | 3 | Strong Buy | $160.00 | N/A | Reiterates | 2 years ago |
Syros Pharmaceuticals IncSYRS | 5 | Strong Buy | $5.00 | N/A | Reiterates | 2 years ago |
Cue Biopharma IncCUE | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Aptose Biosciences IncAPTOF | 4 | Strong Buy | $150.00 | N/A | Maintains | 3 years ago |
Aslan Pharmaceuticals LtdASLN | 5 | Strong Buy | $80.00 | N/A | Reiterates | 3 years ago |
Milestone Pharmaceuticals IncMIST | 3 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Poseida Therapeutics IncPSTX | 3 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Gamida Cell LtdGMDAQ | 2 | Strong Buy | $2.00 | N/A | Maintains | 3 years ago |
Point Biopharma Global IncPNT | 2 | Hold | $12.50 | N/A | Downgrades | 3 years ago |
Gritstone Bio IncGRTSQ | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Rapt Therapeutics IncRAPT | 5 | Strong Buy | $248.00 | N/A | Maintains | 3 years ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.50 | N/A | Downgrades | 3 years ago |
Infinity Pharmaceuticals IncINFI | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Jounce Therapeutics IncJNCE | 3 | Strong Buy | $5.00 | N/A | Maintains | 4 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 4 years ago |
Aravive IncARAV | 1 | Strong Buy | $2.00 | N/A | Maintains | 4 years ago |
Seres Therapeutics IncMCRB | 3 | Strong Buy | $180.00 | N/A | Maintains | 4 years ago |
Puretech Health PLCPRTCY | 1 | Strong Buy | $44.00 | N/A | Maintains | 4 years ago |
Eloxx Pharmaceuticals IncELOX | 2 | Strong Buy | $60.00 | N/A | Maintains | 4 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $37.00 | N/A | Maintains | 4 years ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $100.00 | N/A | Maintains | 4 years ago |
Aptevo Therapeutics IncAPVO | 3 | Strong Buy | $11,721,600.00 | N/A | Maintains | 4 years ago |
Argenx SeARGX | 3 | Strong Buy | $354.00 | N/A | Upgrades | 5 years ago |
Synlogic IncSYBX | 2 | Strong Buy | $135.00 | N/A | Maintains | 5 years ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $323.00 | N/A | Maintains | 5 years ago |
Chemocentryx IncCCXI1 | 1 | Hold | $25.00 | N/A | Downgrades | 5 years ago |
Exelixis IncEXEL | 1 | Strong Buy | $36.00 | N/A | Maintains | 6 years ago |
Kaleido Biosciences IncKLDO | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 6 years ago |
Flyte Aviation IncVJET | 3 | Hold | $25.00 | N/A | Maintains | 6 years ago |
Marker Therapeutics IncMRKR | 2 | Hold | $25.00 | N/A | Downgrades | 6 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Strong Buy | $18.50 | N/A | Reiterates | 7 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | 7 years ago |
Igm Biosciences IncIGMS | 1 | Strong Buy | $53.00 | N/A | Maintains | 7 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $75.00 | N/A | Upgrades | 8 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 9 years ago |
Oncomed Pharmaceuticals IncOMED | 1 | Hold | $5.00 | N/A | Downgrades | 10 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | N/A | N/A | Upgrades | 10 years ago |
Atyr Pharma IncATYR | 1 | Hold | $1,064.00 | N/A | Maintains | 14 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.